Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance.

Baker SB, Cohen M, Kuo L, Johnson M, Al-Attar A, Zukowska Z.

Plast Reconstr Surg. 2009 Feb;123(2):486-92. doi: 10.1097/PRS.0b013e3181954c80.

2.

Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.

Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z.

Ann N Y Acad Sci. 2008 Dec;1148:232-7. doi: 10.1196/annals.1410.035.

3.

Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.

Li L, Najafi AH, Kitlinska JB, Neville R, Laredo J, Epstein SE, Burnett MS, Zukowska Z.

J Cardiovasc Transl Res. 2011 Jun;4(3):351-62. doi: 10.1007/s12265-011-9271-5. Epub 2011 Apr 6.

PMID:
21468772
4.
5.

Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy.

Yoon HZ, Yan Y, Geng Y, Higgins RD.

Clin Exp Ophthalmol. 2002 Dec;30(6):424-9.

PMID:
12427234
6.

Ligands of the neuropeptide Y Y2 receptor.

Mittapalli GK, Roberts E.

Bioorg Med Chem Lett. 2014 Jan 15;24(2):430-41. doi: 10.1016/j.bmcl.2013.11.061. Epub 2013 Dec 4. Review.

7.

Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.

Dimitrijević M, Stanojević S, Vujić V, Beck-Sickinger A, von Hörsten S.

Regul Pept. 2005 Jan 15;124(1-3):163-72.

PMID:
15544855
8.

Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line.

Gericke MT, Kosacka J, Koch D, Nowicki M, Schröder T, Ricken AM, Nieber K, Spanel-Borowski K.

Br J Pharmacol. 2009 Jun;157(4):620-32. doi: 10.1111/j.1476-5381.2009.00164.x. Epub 2009 Apr 27.

9.

Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice.

Huang XF, Yu Y, Li Y, Tim S, Deng C, Wang Q.

Neurochem Res. 2008 Sep;33(9):1881-8. doi: 10.1007/s11064-008-9661-5. Epub 2008 Mar 21.

PMID:
18357520
10.
11.

Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P.

Neuroscience. 2005;136(4):1097-107. Epub 2005 Oct 10.

12.

Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.

Shi YC, Baldock PA.

Bone. 2012 Feb;50(2):430-6. doi: 10.1016/j.bone.2011.10.001. Epub 2011 Oct 11. Review.

PMID:
22008645
13.

Dietary overload lithium decreases the adipogenesis in abdominal adipose tissue of broiler chickens.

Bai S, Pan S, Zhang K, Ding X, Wang J, Zeng Q, Xuan Y, Su Z.

Environ Toxicol Pharmacol. 2017 Jan;49:163-171. doi: 10.1016/j.etap.2016.12.012. Epub 2016 Dec 26.

PMID:
28049100
14.

A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.

Potter EK, Barden JA, McCloskey MJ, Selbie LA, Tseng A, Herzog H, Shine J.

Eur J Pharmacol. 1994 May 17;267(3):253-62.

PMID:
8088364
15.
16.

Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes.

Rosmaninho-Salgado J, Cortez V, Estrada M, Santana MM, Gonçalves A, Marques AP, Cavadas C.

Neuropeptides. 2012 Dec;46(6):359-66. doi: 10.1016/j.npep.2012.08.006. Epub 2012 Sep 13.

PMID:
22981159
17.

Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model.

Philips BJ, Grahovac TL, Valentin JE, Chung CW, Bliley JM, Pfeifer ME, Roy SB, Dreifuss S, Kelmendi-Doko A, Kling RE, Ravuri SK, Marra KG, Donnenberg VS, Donnenberg AD, Rubin JP.

Plast Reconstr Surg. 2013 Oct;132(4):845-58. doi: 10.1097/PRS.0b013e31829fe5b1.

18.

Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.

Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM.

J Bone Miner Res. 2005 Oct;20(10):1851-7. Epub 2005 May 31.

19.

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome.

Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z.

Nat Med. 2007 Jul;13(7):803-11. Epub 2007 Jul 1. Erratum in: Nat Med. 2007 Sep;13(9):1120.

PMID:
17603492
20.

Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.

Hyland NP, Sjöberg F, Tough IR, Herzog H, Cox HM.

Br J Pharmacol. 2003 Jun;139(4):863-71.

Supplemental Content

Support Center